Search - tctmd.com

Displaying 241 - 260 of 294

Sort: Relevancy | Date

News Conference News ACC 2018

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Michael O'Riordan

March 11, 2018

News Daily News

FDA: Clarithromycin Risks Persist in Patients With CAD

Todd Neale

February 26, 2018

News Daily News

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Michael O'Riordan

February 02, 2018

News Daily News

Nonstatin Use and Expenditures Are Up Despite the Dearth of Evidence Supporting Efficacy

Yael L. Maxwell

January 29, 2018

News Daily News

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Caitlin E. Cox

January 18, 2018

News Daily News

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

Yael L. Maxwell

January 09, 2018

News Conference News AHA 2017

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

Yael L. Maxwell

November 27, 2017

News Conference News AHA 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Caitlin E. Cox

November 14, 2017

News Conference News AHA 2017

Long-Awaited Hypertension Guidelines Released at AHA

Todd Neale

November 13, 2017

News Daily News

PCSK9 Inhibitors: More Data Show Disappointing Approval Rates of Prescriptions by Payers

Yael L. Maxwell

October 30, 2017

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News Daily News

ACC Updates Recommendations for Non-statin Therapy Use for LDL-Cholesterol Lowering in Secondary Prevention

Yael L. Maxwell

September 06, 2017

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

News Daily News

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Michael O'Riordan

August 02, 2017

News Conference News SCCT 2017

Coronary Calcium Scores in 2017: Useful, Yes, but Hard Outcomes Data Still Lacking

Yael L. Maxwell

July 13, 2017

News Daily News

Identifying CAD in Stable Patients: CT Imaging or Start With Functional Testing?

Yael L. Maxwell

July 12, 2017

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Daily News

Conflicts of Interest in the 2013 Cholesterol Guidelines? New Analysis Revisits the Controversy

Caitlin E. Cox

January 17, 2017

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

Advertisement

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

FDA: Clarithromycin Risks Persist in Patients With CAD

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Nonstatin Use and Expenditures Are Up Despite the Dearth of Evidence Supporting Efficacy

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Cardiovascular Disease and Risk Factors Increasing Among Patients Undergoing Noncardiac Surgery

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

Long-Awaited Hypertension Guidelines Released at AHA

PCSK9 Inhibitors: More Data Show Disappointing Approval Rates of Prescriptions by Payers

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

ACC Updates Recommendations for Non-statin Therapy Use for LDL-Cholesterol Lowering in Secondary Prevention

Evolocumab Not Cost-Effective at Current List Price

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Coronary Calcium Scores in 2017: Useful, Yes, but Hard Outcomes Data Still Lacking

Identifying CAD in Stable Patients: CT Imaging or Start With Functional Testing?

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Conflicts of Interest in the 2013 Cholesterol Guidelines? New Analysis Revisits the Controversy

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content